AlemtuzumabAutoimmune disorders: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2015年 / 1539卷 / 1期

关键词：

D O I：

10.1007/s40278-015-7575-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：20 / 20

相关论文

共 50 条

[1] AlemtuzumabAutoimmune thyroid disease: 4 case reports
Reactions Weekly, 2014, 1483 (1) : 7 - 7
[2] AlemtuzumabAutoimmune thyroid disorders, Hashimoto thyroiditis and Grave's disease: 4 case reports
Reactions Weekly, 2019, 1737 (1) : 22 - 22
[3] AlemtuzumabAutoimmune nephropathy: 9 case reports
Reactions Weekly, 2020, 1813 (1) : 17 - 17
[4] AlemtuzumabAutoimmune diseases: 5 case reports
Reactions Weekly, 2019, 1775 (1) : 25 - 25
[5] AlemtuzumabAutoimmune diseases: 3 case reports
Reactions Weekly, 2021, 1846 (1) : 17 - 17
[6] AlemtuzumabAutoimmune thyroid disorders: case report
Reactions Weekly, 2021, 1842 (1) : 18 - 18
[7] AlemtuzumabAutoimmune thrombopenia and chronic urticaria: 2 case reports
Reactions Weekly, 2021, 1842 (1) : 17 - 17
[8] AlemtuzumabAutoimmune thyroid disease presenting as primary hypothyroidism, thyroiditis and hyperthyroidism: 4 case reports
Reactions Weekly, 2020, 1832 (1) : 22 - 22
[9] AlemtuzumabAutoimmune haemolytic anaemia, immune thrombocytopenia and Grave's disease: 4 case reports
Reactions Weekly, 2019, 1743 (1) : 19 - 19
[10] ErlotinibHaematological disorders: 4 case reports
Reactions Weekly, 2010, 1309 (1) : 19 - 19

← 1 2 3 4 5 →